|Articles|February 1, 2019
- Pharmaceutical Executive-02-01-2019
- Volume 39
- Issue 2
Pharmaceutical Executive, February 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Q&A: Regulatory Reform in Chinaover 6 years ago
China: A Change in Attitudeover 6 years ago
New Roads to Chinaover 6 years ago
Closing the Pharma and Digital Health Divideover 6 years ago
A Leading Man’s Next Actover 6 years ago
Two Steps Forwardover 6 years ago
Let the Drug Pricing Games Beginover 6 years ago
Mixed Outlook for China Life Sciencesover 6 years ago
CFIUS Reform’s Impact on Biopharmaover 6 years ago
Op-Ed: Opening the Golden DoorNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
